Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
11.9%
% of IYH's 113 holdings also in MEDX
43.3%
% of MEDX's 30 holdings also in IYH
Overlap by Weight
Sector Drift (IYH minus MEDX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IYH |
Weight in MEDX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.7% | 15.1% | 11.7% |
|
ABBVIE INC | 5.2% | 7.3% | 5.2% |
|
MERCK & CO. INC. | 6.0% | 5.2% | 5.2% |
|
JOHNSON & JOHNSON | 6.6% | 4.5% | 4.5% |
|
AMGEN INC | 3.0% | 6.1% | 3.0% |
Position Highlights (Non-Overlapping Exposures)
IYH Overweight Relative to MEDX
|
UNITEDHEALTH GROUP INC | 8.7% |
|
THERMO FISHER SCIENTIFIC INC | 4.2% |
|
ABBOTT LABORATORIES | 3.3% |
|
DANAHER CORP | 3.0% |
|
INTUITIVE SURGICAL INC | 2.5% |
|
ELEVANCE HEALTH INC | 2.3% |
|
STRYKER CORP | 2.1% |
|
JOHNSON & JOHNSON | 2.1% |
 |
MEDTRONIC PLC | 2.0% |
|
VERTEX PHARMACEUTICALS INC | 2.0% |
IYH Underweight Relative to MEDX
 |
NOVARTIS AG-ADR | -5.8% |
 |
ASTRAZENECA PLC-SPONS ADR | -5.7% |
|
BIOGEN IDEC INC | -3.5% |
|
ELI LILLY & CO | -3.4% |
|
ALKERMES PLC | -3.3% |
|
CRISPR THERAPEUTICS AG | -3.2% |
|
AMGEN INC | -3.1% |
|
BRISTOL-MYERS SQUIBB CO | -3.0% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -3.0% |
|
IONIS PHARMACEUTICALS, INC. | -2.8% |